Exclusive domestic supply agreement for ‘Derma Atom’ with GCS Co., Ltd.

Korea’s first ‘heparin sodium’ raw drug substance DMF registration and sales approval

HA filler ‘Elravie Premier’ approved for Russian product

Domestic exclusive contract with Ensolbioscience for osteoarthritis treatment 'E1K'

Launch of ‘Derma Revie’ a joint venture brand with China’s Shang-Li Biotech

Signed a strategic investment agreement with Ensolbioscience

Acquired IS0 37301 certification for compliance management system

Ministry of Food and Drug Safety, QbD(Quality by design) Technical Support Project Selection

Selected as an excellent company research institute fostering project (Ministry of Trade, Industry and Energy)

"Exosome-based therapeutics and cosmetics development business agreement" with Exostemtech

Selected as an excellent corporation for public disclosure on the KOSDAQ market in 2021

Joint development agreement with G2GBio for "Long-term efficacy lasting injection"

Acquisition of integrated certification for safety and health management system

Selected as a COVID-19 Vaccine production Facility and Equipment support project
(Korea Health Industry Development Institute)

Ultra-high low molecule HA Registration

Changed the location of the head office "Pangyo I-Square"

"Humia", Acquired European CE certification

Long-acting obesity/diabetes injection development agreement with HLB pharmaceutical

Anti-aging "Idebenone Composition" Patent

Awarded “$10 Million Export Tower”

Exported ‘COVID-19’ Rapid Diagnostic Kit

Approved as “Doublofill” from KFDA

Received an excellent family-friendly company(MOGEF)

Dermal filler ‘Elraive Deep Line-L’ formally registered in China NMPA

Humedix & Wooribnb Strategic Alliance

‘Dermal Elraive’ Cosmetics formally registered in China NMPA

Kim Jin-hwan inaugurated as CEO

'LIZTOX' launched

Approved as “HUMIA” from KFDA

Approved as Dermal filler “Elravie premier volumizing” from KFDA

Gyeonggi Venture Company Award(Gyeonggi Venture Business Association)

Awarded Excellent Employment Company of Chungcheongbuk-do

Contract with Sesderma of Spain to transfer filler technology

Awarded for gender equality(Jecheon City)

KICOX Global Leading Company Award

Humedix & AriBio Strategic Alliance

Revitalex launched

Patented bee venom cosmetic composition

Launched Panace medical device ‘DermaAKNE’

Launched three kinds of Derma Elraive masks

Completed cGMP class Jecheon new factory

Chung Koo-wan inaugurated as CEO

Launched three kinds of Elraive aseptic cosmetics

'Asia's 200 Most Promising Companies' selected by Forbes Asia

Acquired a medical device company ‘Panace’

Hyaluronic Acid Filler Elraive obtained European CE Certification

Hyaluronic Acid Filler development technology selected as ‘2015 100 National R & D Excellent achievements’ selected as the Ministry of Science, ICT and Future Planning

Selected as 2015 Excellent Enterprise in Anyang City

Elraive Filler Deep Line Plus launched in China

Dermal filler ‘Elraive Deep Line Plus’ formally registered in China Food and Drug Administration (CFDA)

Signed an investment agreement to expand the second factory in Chungcheongbuk-do / Jecheon

Listed on KOSDAQ

Global Hidden Champion Promotion Project Agreement (Korea Research Institute of Bioscience and Biotechnology)

Designated as a promising export small and medium enterprise (Gyeonggi-do Small and Medium Business Administration)

Declared Humedix Vision

Jeong Bong-ryeol inaugurated as CEO

Built three kinds of filler line-up

Beauty filler ‘Elraive’ acquired permission from Korea Food and Drug Administration (KFDA)

Started construction and sales of functional biopolymers, Hu-PEGs Library

Re-designated as a venture company

Change the company name into Humedix Co., Ltd.

Incorporated as a subsidiary of Huons Global Co., Ltd.

Acquired the individual recognition of PF-501 health functional foods

cGMP Certification for Jecheon Factory

Certification for Jecheon Factory

Changed the company name into HVLS Co., Ltd.

Acquired license for pharmaceutical manufacturing

Registered as an Inno-Biz company (Small and Medium Business Administration)

Selected as an organization responsible for agricultural and forestry technology development project

Selected as a business operator responsible for TLO transfer Technology R & D Project of Industrial Technology Association

Selected as an Oriental medicine biofusion research support provider organized by the Ministry of Health and Welfare

Selected as an excellent Venture Globalization Support Provider organized by the Small and Medium Business Administration

IMS Information System Management System Certification organized by the Small and Medium Business Administration

Selected as a technology development project for transferring SMEs

Designated as a venture company

Established affiliated Research Institute ‘Natural Substance New drugs Research Institute’

Selected as an export enterprise operator (Small and Medium Business Administration)

Selected as an excellent new technology provider by the Ministry of Commerce, Industry and Energy

Converted to Chinese Medicine Village Co., Ltd.